EdiTy Therapeutics vs Upstream Bio
EdiTy Therapeutics vs Upstream Bio, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: EdiTy Therapeutics is on 19/100 and Upstream Bio on 61/100.
Where each one leads
EdiTy Therapeutics
Leads on none of the measures we hold for both companies.
Upstream Bio
- our overall score: 61/100 against 19/100
- domain rating: 32/100 against 5/100
- headcount: 75 against 16
- LinkedIn following: 11,799 against 799
At a glance
| Measure | EdiTy Therapeutics | Upstream Bio |
|---|---|---|
| What it is | Developing a novel immune cell-based delivery platform for intracellular therapeutic protein transfer. | Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases. |
| Category | Life Sciences, Immunology, Biotech, Genome Editing | Life Sciences, Therapeutics, Biotech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Services |
| Founded | 2020 | 2021 |
| Headquarters | Not published | Waltham, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | EdiTy Therapeutics | Upstream Bio |
|---|---|---|
| Employees | 16 | 75 |
| Headcount growthLast 12 months | Not published | +43.4% |
| Total funding | Not published | $400M |
| Latest round | Seed | Series B |
| LinkedIn followers | 799 | 11,799 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | EdiTy Therapeutics | Upstream Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 19/100 | 61/100 |
| Traction | 12/100 | 59/100 |
| Team | Not published | 70/100 |
| Search visibility | 28/100 | 37/100 |
| Quality | Not published | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 5/100 | 32/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | EdiTy Therapeutics | Upstream Bio |
|---|---|---|
| Hosting | Google Cloud | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Not detected | Jquery, Bootstrap |
| Analytics | Not detected | Google Tag Manager |
EdiTy Therapeutics vs Upstream Bio: common questions
Which is better, EdiTy Therapeutics or Upstream Bio?
On our 0-100 score Upstream Bio rates higher (61/100 against 19/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do EdiTy Therapeutics and Upstream Bio compare on the numbers?
Upstream Bio leads on our overall score (61/100 against 19/100), domain rating (32/100 against 5/100), headcount (75 against 16), LinkedIn following (11,799 against 799).
Read the full EdiTy Therapeutics review and pricing or the Upstream Bio review and pricing. You can also browse other EdiTy Therapeutics alternatives we track.